Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?
Shuk-Ching Wong, Lithia Lai-Ha Yuen, Veronica Wing-Man Chan, Jonathan Hon-Kwan Chen, Kelvin Kai-Wang To, Kwok-Yung Yuen, Vincent Chi-Chung Cheng
Author Information
- Shuk-Ching Wong: Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China.
- Lithia Lai-Ha Yuen: Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China.
- Veronica Wing-Man Chan: Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China.
- Jonathan Hon-Kwan Chen: Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
- Kelvin Kai-Wang To: Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
- Kwok-Yung Yuen: Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
- Vincent Chi-Chung Cheng: Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China.
No abstract text available.
Humans
SARS-CoV-2
Respiratory Aerosols and Droplets
COVID-19
Communicable Disease Control
Cross Infection
